Lumefantrine
From Wikipedia, the free encyclopedia
Lumefantrine
|
|
Systematic (IUPAC) name | |
2-(dibutylamino)-1-[(9E)-2,7-dichloro- 9-[(4-chlorophenyl)methylidene] fluoren-4-yl]ethanol | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C30H32Cl3NO |
Mol. mass | 528.939 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Lumefantrine (or benflumetol) is an antimalarial drug.
The term "co-artemether" is sometimes used to describe the administration of lumefantrine with artemether.[1]
[edit] References
- ^ Toovey S, Jamieson A, Nettleton G (2003). "Successful co-artemether (artemether-lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique". Travel medicine and infectious disease 1 (3): 177–9. doi: . PMID 17291911.
|